Pfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drug
The Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the Food and Drug Administration granted Pfizer full approval Thursday to market the pills. "At this time,…
#pfizer #paxlovid #dawnoconnell #response #healthaffairs #oconnell #aspr #responsecoordinator #ashishjha #fda